Secretome Therapeutics

A New Standard in Regenerative Medicine.

Baltimore, United States · Founded 2018 · $52.4M raised

Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$52.4M
Last Round
$30.0M Series AMay 2026
Rounds
5

About

Secretome Therapeutics (formerly NeoProgen) is a clinical-stage biotechnology company developing novel regenerative medicines derived from neonatal cardiac progenitor cells. Lead candidate STM-01 targets heart failure with preserved ejection fraction, dilated cardiomyopathy, and Duchenne-associated cardiomyopathy.

Summary

Secretome Therapeutics is a Biotech company based in Baltimore, United States, founded in 2018. It has raised $52.4M in total across 5 rounds, most recently a $30.0M Series A round in May 2026. Investors include RA Capital Management and Parent Project Muscular Dystrophy.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2026
$30.0M

Sign up to see all 5 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Secretome Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/secretome-therapeutics"><img src="https://indexed.vc/api/badge/company/secretome-therapeutics" alt="Secretome Therapeutics on Indexed.vc" width="260" height="76" /></a>